{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:23:58Z","timestamp":1789475038612,"version":"build-2803163510"},"reference-count":27,"publisher":"American Diabetes Association","issue":"4","license":[{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,11,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Reduction of atherosclerotic cardiovascular disease (ASCVD) risk in patients with diabetes requires proper management of lipid parameters. This study aimed to find the pattern of dyslipidemia and scope of ASCVD risk reduction in patients with diabetes by lipid management.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>Clinical, biochemical, and medication profiles of all patients with diabetes attending a tertiary diabetes care hospital over a 2-year period were collected. The prevalence of various lipid abnormalities was determined after excluding patients with thyroid dysfunction and those on lipid-lowering medications. Patients were stratified according to LDL cholesterol, HDL cholesterol, and triglyceride levels, and other clinical parameters were compared among the groups. The adequacy of statin treatment was assessed based on American Diabetes Association guidelines.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Nine hundred and seventy-one patients were included. The prevalence of hyperlipidemia was 40.0%, of whom 14.6% were newly diagnosed. The most common lipid abnormality was elevated LDL cholesterol. Higher A1C and fasting blood glucose values were found to be associated with higher LDL cholesterol levels. Twenty-seven percent of patients with indications for treatment with statins were receiving them. Of those being treated with statins, 42.6% had an LDL cholesterol level \u2265100 mg\/dL.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSION<\/jats:title>\n                  <jats:p>In South Indian patients with type 2 diabetes and fair glycemic control, high LDL cholesterol is the predominant lipid abnormality. There remains a huge potential for ASCVD risk reduction in this population if the knowledge practice gap is addressed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/ds19-0046","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T20:34:29Z","timestamp":1585946069000},"page":"299-306","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":17,"title":["Lipid Profile in Indian Patients With Type 2 Diabetes: The Scope for Atherosclerotic Cardiovascular Disease Risk Reduction"],"prefix":"10.2337","volume":"33","author":[{"given":"Chellamma","family":"Jayakumari","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Government Medical College, Thiruvananthapuram, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puthiyaveettil Khadar","family":"Jabbar","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Government Medical College, Thiruvananthapuram, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarayu","family":"Soumya","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Government Medical College, Thiruvananthapuram, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.V.","family":"Jayakumar","sequence":"additional","affiliation":[{"name":"Indian Institute of Diabetes, Thiruvananthapuram, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darvin Vamadevan","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Government Medical College, Thiruvananthapuram, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopi","family":"Girivishnu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Government Medical College, Thiruvananthapuram, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjana","family":"Gopi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, ESIC Model and Superspecialty Hospital, Kollam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Gomez","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Government Medical College, Thiruvananthapuram, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindranath","family":"Sreenath","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Government Medical College, Thiruvananthapuram, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6776-1582","authenticated-orcid":false,"given":"Abilash","family":"Nair","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Government Medical College, Thiruvananthapuram, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031221400372900_B1","doi-asserted-by":"crossref","first-page":"e1002581","DOI":"10.1371\/journal.pmed.1002581","article-title":"Geographic and sociodemographic variation of cardiovascular disease risk in India: a cross-sectional study of 797,540 adults","volume":"15","author":"Geldsetzer","year":"2018","journal-title":"PLoS Med"},{"key":"2022031221400372900_B2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrendo.2016.53","article-title":"Diabetes mellitus and its complications in India","volume":"12","author":"Unnikrishnan","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"2022031221400372900_B3","doi-asserted-by":"crossref","first-page":"6989453","DOI":"10.1155\/2016\/6989453","article-title":"Complications of diabetes, 2016","volume":"2016","author":"Papatheodorou","year":"2016","journal-title":"J Diabetes Res"},{"key":"2022031221400372900_B4","first-page":"2201","article-title":"Prevalence of dyslipidemia in South Indian adults: an urban-rural comparison","volume":"3","author":"Ajay","year":"2016","journal-title":"Int J Community Med Public Health"},{"key":"2022031221400372900_B5","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.clinthera.2015.03.020","article-title":"Statin prescribing patterns: an aanalysis of data from patients with diabetes in the National Hospital Ambulatory Medical Care Survey Outpatient Department and National Ambulatory Medical Care Survey databases, 2005\u20132010","volume":"37","author":"Pauff","year":"2015","journal-title":"Clin Ther"},{"key":"2022031221400372900_B6","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1097\/HJH.0b013e32833b4953","article-title":"Factors associated with therapeutic inertia in hypertension: validation of a predictive model","volume":"28","author":"Red\u00f3n","year":"2010","journal-title":"J Hypertens"},{"key":"2022031221400372900_B7","doi-asserted-by":"crossref","first-page":"5386129","DOI":"10.1155\/2018\/5386129","article-title":"Prevalence and associations of hypothyroidism in Indian patients with type 2 diabetes mellitus","volume":"2018","author":"Nair","year":"2018","journal-title":"J Thyroid Res"},{"key":"2022031221400372900_B8","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.2337\/dc19-S010","article-title":"10. Cardiovascular disease and risk management: Standards of Medical Care in Diabetes\u20142019","volume":"42","author":"American Diabetes Association","year":"2019","journal-title":"Diabetes Care"},{"key":"2022031221400372900_B9","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1210\/jcem.86.3.7304","article-title":"Diabetic dyslipidemia: causes and consequences","volume":"86","author":"Goldberg","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031221400372900_B10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.dsx.2016.07.005","article-title":"A study on the glycemic, lipid and blood pressure control of type 2 diabetes patients of Kerala","volume":"11","author":"Suresh","year":"2017","journal-title":"Diabetes Metab Syndr"},{"key":"2022031221400372900_B11","first-page":"56","article-title":"A study of lipid profile in diabetes mellitus","volume":"4","author":"Jain","year":"2016","journal-title":"Int J Sci Study"},{"key":"2022031221400372900_B12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1476-511X-13-183","article-title":"Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study","volume":"13","author":"Ozder","year":"2014","journal-title":"Lipids Health Dis"},{"key":"2022031221400372900_B13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.18376\/\/2012\/v8i1\/67599","article-title":"A study of lipid profile in type 2 diabetic Punjabi population","volume":"8","author":"Singh","year":"2012","journal-title":"Journal of Exercise Science and Physiotherapy"},{"key":"2022031221400372900_B14","doi-asserted-by":"crossref","first-page":"e0193756","DOI":"10.1371\/journal.pone.0193756","article-title":"Trends in lipid profiles and descriptive characteristics of U.S. adults with and without diabetes and cholesterol-lowering medication use: National Health and Nutrition Examination Survey, 2003\u20132012, United States","volume":"13","author":"Mercado","year":"2018","journal-title":"PLoS One"},{"key":"2022031221400372900_B15","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)13636-7","article-title":"MRC\/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial","volume":"361","author":"Collins","year":"2003","journal-title":"Lancet"},{"key":"2022031221400372900_B16","doi-asserted-by":"crossref","first-page":"235742","DOI":"10.1155\/2015\/235742","article-title":"Systemic inflammatory markers are closely associated with atherogenic lipoprotein subfractions in patients undergoing coronary angiography","volume":"2015","author":"Zhang","year":"2015","journal-title":"Mediators Inflamm"},{"key":"2022031221400372900_B17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/01.CIR.96.1.37","article-title":"Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984\u20131994","volume":"96","author":"Ferrara","year":"1997","journal-title":"Circulation"},{"key":"2022031221400372900_B18","doi-asserted-by":"crossref","first-page":"e000275","DOI":"10.1136\/bmjdrc-2016-000275","article-title":"Evaluation of statin prescriptions in type 2 diabetes: India Heart Watch-2","volume":"4","author":"Gupta","year":"2016","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2022031221400372900_B19","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2337\/diaspect.26.3.156","article-title":"The role of statins in diabetes treatment","volume":"26","author":"Subedi","year":"2013","journal-title":"Diabetes Spectr"},{"key":"2022031221400372900_B20","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"2022031221400372900_B21","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","article-title":"Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations in the Anglo-Scandinavian Cardiac Outcomes Trial\u2013Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"2022031221400372900_B22","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1001\/jama.288.23.2998","article-title":"Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)","volume":"288","author":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group","year":"2002","journal-title":"JAMA"},{"key":"2022031221400372900_B23","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(06)69472-5","article-title":"Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial","volume":"368","author":"Nakamura","year":"2006","journal-title":"Lancet"},{"key":"2022031221400372900_B24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2337\/dci17-0057","article-title":"Cardiovascular outcomes trials in type 2 diabetes: where do we go from here? Reflections from a Diabetes Care Editors\u2019 Expert Forum","volume":"41","author":"Cefalu","year":"2018","journal-title":"Diabetes Care"},{"key":"2022031221400372900_B25","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.2337\/dc09-0738","article-title":"Statin therapy and risk of developing type 2 diabetes: a meta-analysis","volume":"32","author":"Rajpathak","year":"2009","journal-title":"Diabetes Care"},{"key":"2022031221400372900_B26","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"2022031221400372900_B27","doi-asserted-by":"crossref","first-page":"2042018819844694","DOI":"10.1177\/2042018819844694","article-title":"Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertia","volume":"10","author":"Khunti","year":"2019","journal-title":"Ther Adv Endocrinol Metab"}],"container-title":["Diabetes Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/spectrum\/article-pdf\/33\/4\/299\/505493\/diaspectds190046.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/spectrum\/article-pdf\/33\/4\/299\/505493\/diaspectds190046.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T23:56:24Z","timestamp":1647129384000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/spectrum\/article\/33\/4\/299\/32565\/Lipid-Profile-in-Indian-Patients-With-Type-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,1]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.2337\/ds19-0046","relation":{},"ISSN":["1040-9165","1944-7353"],"issn-type":[{"value":"1040-9165","type":"print"},{"value":"1944-7353","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,1]]}}}